Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine vs. Standard Care Rescue Medication in TKA Patients
NCT07796152Phase 4Not yet recruiting
- Sponsor
- Endeavor Health
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of suzetrigine in postoperative pain (2 arms), sponsored by Endeavor Health. Primary endpoint: Pain score (Numeric Rating Scale) at Day 30. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07796152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796152.